Subtitles section Play video
-
AstraZeneca's communication could do with a booster shot, $134 billion drug giant is launching another review to check the effectiveness of its covert 19 vaccination.
-
This all started on Monday when CEO Pascal saw Rio said that it's vaccination could be asshole I as 90% effective, but the only problem is that 90% figure relates to a small portion of the trial.
-
For the majority of candidates, the number was 62%.
-
To confuse things further, the University of Oxford, which is partnering with AstraZeneca, lead with a 70% figure, which was an average of the 90% and the 62% combined.
-
It's understandable why Sorry oh would have led with a higher number.
-
Over the past few weeks, Madonna and Pfizer have said that their vaccinations are as high as 95% effective.
-
But the problem with muddying up the communication on this is that it undermines public confidence in vaccinations at a time when people are very fearful with how fast these vaccinations have been created.
-
Over the past week, Astra Zeneca shares have fallen and investors are watching closely.
-
And as the world prepares to take billions of doses of vaccinations.
-
Fumbling over your communication is the last place of drug giant wants to be.